Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease

doi:10.4254/wjh.v6.i8.570

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 8

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10274)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series.

Item

Count

PDF

727

WORD

352

HTML

6214

Figures (1-5)

290

Sum=7583

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1296

Download

1395

Sum=2691

Aug 27, 2014 (publication date) through Nov 7, 2024

Times Cited of This Article

Times Cited (79)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Aug 27, 2014; 6(8): 570-579
Published online Aug 27, 2014. doi: 10.4254/wjh.v6.i8.570

Full Size Figure Download Figure

Figure 5 Changes of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease. TGFβ1: Transforming growth factor beta 1; TNF-α: Tumor necrosis factor alpha; RBP4: Retinol binding protein 4. NAFLD: Nonalcoholic fatty liver disease; PPAR: Peroxisome proliferator-activated receptors.

Citation: Giby VG, Ajith TA. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease. World J Hepatol 2014; 6(8): 570-579
URL: https://www.wjgnet.com/1948-5182/full/v6/i8/570.htm
DOI: https://dx.doi.org/10.4254/wjh.v6.i8.570